Successful development of small diameter tissue-engineering vascular vessels by our novel integrally designed pulsatile perfusion-based bioreactor

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Song, Lei ^a   Zhou, Qiang ^a   Duan, Ping ^a   Guo, Ping ^a   Li, Dianwei ^a   Xu, Yuan ^a   Li, Songtao ^a   Luo, Fei ^a   Zhang, Zehua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOREACTOR; BIOREACTOR DESIGN; BLOOD VESSEL DIAMETER; CELL PROLIFERATION; COMPUTER SYSTEM; CULTURE MEDIUM; FLUID FLOW; INTERMETHOD COMPARISON; MATERIALS TESTING; MECHANICAL STIMULATION; METABOLIC REGULATION; NONHUMAN; NUTRIENT AVAILABILITY; PROCESS OPTIMIZATION; RABBIT; RAT; TENSILE STRENGTH; THROMBOCYTE ADHESION; TISSUE CULTURE; TISSUE ENGINEERING; TISSUE GRAFT; TISSUE LEVEL; VASCULAR PATENCY; VASCULAR TISSUE; YOUNG MODULUS;

ANIMALS; BIOMECHANICS; BIOREACTORS; BLOOD VESSELS; CELL SURVIVAL; COLLAGEN; ENDOTHELIN-1; EPOPROSTENOL; GENE EXPRESSION REGULATION; NITRIC OXIDE; PHENOTYPE; PRESSURE; PULSATILE FLOW; RABBITS; RATS; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84864535128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042569     Document Type: Article

References (33)

1. Isenberg BC, Williams C, Tranquillo RT, ((2006)) Small-diameter artificial arteries engineered in vitro. Circ Res 98:: 25--35.
2. Teebken OE, Haverich A, ((2002)) Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 23:: 475--485.
3. Bordenave L, Menu P, Baquey C, ((2008)) Developments towards tissue-engineered, small-diameter arterial substitutes. Expert Rev Med Devices 5:: 337--347.
4. Williams C, Wick TM, ((2004)) Perfusion bioreactor for small diameter tissue-engineered arteries. Tissue Eng 10:: 930--941.
5. Pei M, Solchaga LA, Seidel J, Zeng L, Vunjak-Novakovic G, et al. ((2002)) Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J 16:: 1691--1694.
6. Ando J, Tsuboi H, Korenaga R, Takada Y, Toyama-Sorimachi N, et al. ((1994)) Shear stress inhibits adhesion of cultured mouse endothelial cells to lymphocytes by downregulating VCAM-1 expression. Am J Physiol 267:: C679--687.
7. Seliktar D, Black RA, Vito RP, Nerem RM, ((2000)) Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 28:: 351--362.
8. Niklason LE, Ratcliffe A, Brockbank K, Bruley DF, Kang KA, ((2002)) Bioreactors and bioprocessing: breakout session summary. Ann N Y Acad Sci 961:: 220--222.
9. Kevil CG, Bullard DC, ((2001)) In vitro culture and characterization of gene targeted mouse endothelium. Acta Physiol Scand 173:: 151--157.
10. Miyatake SI, Yukawa H, TodaH, Matsuoka N, Takahashi R,et al. (1999) Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by recombinant replication-competent herpes simplex virus. Stroke 30: 2431-2438; discussion 2438-2439.
11. Kim WH, Chon CY, Moon YM, Kang JK, Park IS, et al. ((1993)) Effect of anticancer drugs and desferrioxamine in combination with radiation on hepatoma cell lines. Yonsei Med J 34:: 45--56.
12. Naito Y, Williams-Fritze M, Duncan DR, Church SN, Hibino N, et al. ((2011)) Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs 195:: 60--72.
13. Gao F, Gao E, Yue TL, Ohlstein EH, Lopez BL, et al. ((2002)) Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105:: 1497--1502.
14. Ou W, Qiu H, Chen Z, Xu K, ((2011)) Biodegradable block poly(ester-urethane)s based on poly(3-hydroxybutyrate-co-4-hydroxybutyrate) copolymers. Biomaterials 32:: 3178--3188.
15. Xia Z, Gu J, Ansley DM, Xia F, Yu J, ((2003)) Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. J Thorac Cardiovasc Surg 126:: 1404--1410.
16. Ball SG, Shuttleworth AC, Kielty CM, ((2004)) Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 36:: 714--727.
17. Thompson CA, Colon-Hernandez P, Pomerantseva I, MacNeil BD, Nasseri B, et al. ((2002)) A novel pulsatile, laminar flow bioreactor for the development of tissue-engineered vascular structures. Tissue Eng 8:: 1083--1088.
18. McFetridge PS, Abe K, Horrocks M, Chaudhuri JB, ((2007)) Vascular tissue engineering: bioreactor design considerations for extended culture of primary human vascular smooth muscle cells. ASAIO J 53:: 623--630.
19. Lohn M, Lauterbach B, Haller H, Pongs O, Luft FC, et al. ((2001)) beta(1)-Subunit of BK channels regulates arterial wall[Ca(2+)] and diameter in mouse cerebral arteries. J Appl Physiol 91:: 1350--1354.
20. Evans BK, Mason R, Wilson VG, ((1992)) Evidence for direct vasoconstrictor activity of melatonin in "pressurized" segments of isolated caudal artery from juvenile rats. Naunyn Schmiedebergs Arch Pharmacol 346:: 362--365.
21. Crapo PM, Wang Y, ((2011)) Hydrostatic pressure independently increases elastin and collagen co-expression in small-diameter engineered arterial constructs. J Biomed Mater Res A 96:: 673--681.
22. Yang J, Motlagh D, Webb AR, Ameer GA, ((2005)) Novel biphasic elastomeric scaffold for small-diameter blood vessel tissue engineering. Tissue Eng 11:: 1876--1886.
23. Stock UA, Vacanti JP, ((2001)) Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng 7:: 1--7.
24. Wang C, Cen L, Yin S, Liu Q, Liu W, et al. ((2009)) A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 31:: 621--630.
25. Narita Y, Hata K, Kagami H, Usui A, Ueda M, et al. ((2004)) Novel pulse duplicating bioreactor system for tissue-engineered vascular construct. Tissue Eng 10:: 1224--1233.
26. Sodian R, Lemke T, Fritsche C, Hoerstrup SP, Fu P, et al. ((2002)) Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering. Tissue Eng 8:: 863--870.
27. McCulloch AD, Harris AB, Sarraf CE, Eastwood M, ((2004)) New multi-cue bioreactor for tissue engineering of tubular cardiovascular samples under physiological conditions. Tissue Eng 10:: 565--573.
28. Radomski MW, Palmer RM, Moncada S, ((1987)) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:: 639--646.
29. Tanaka Y, Yamaki F, Koike K, Toro L, ((2004)) New insights into the intracellular mechanisms by which PGI2 analogues elicit vascular relaxation: cyclic AMP-independent, Gs-protein mediated-activation of MaxiK channel. Curr Med Chem Cardiovasc Hematol Agents 2:: 257--265.
30. Gross S, Tilly P, Hentsch D, Vonesch JL, Fabre JE, ((2007)) Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. J Exp Med 204:: 311--320.
31. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, et al. ((1999)) Functional arteries grown in vitro. Science 284:: 489--493.
32. Buttafoco L, Kolkman NG, Engbers-Buijtenhuijs P, Poot AA, Dijkstra PJ, et al. ((2006)) Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 27:: 724--734.
33. Cho SW, Lim SH, Kim IK, Hong YS, Kim SS, et al. ((2005)) Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 241:: 506--515.